Clinical Trial Update: Interferon for the Intervention of Molecular Relapse in t (8; 21) AML After Allo-HSCT [Phase 4]

View source ↗

Summary

This entry provides an update on a Phase 4 clinical trial evaluating interferon for intervention of molecular relapse in t(8;21) acute myeloid leukemia after al…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Interferon (interferon)

Snippet

Sponsor: Peking University People's Hospital | Conditions: Acute Myeloid Leukemia | Phase 4 | Status: UNKNOWN